Companies /Healthcare

Lantheus Holdings Inc

NASDAQ: LNTH Drug Manufacturers - Specialty & Generic
$100.25
▼ $0.14 (−0.14%) today
Markets closed · 4:37pm ET
Today · % change

24/7 Wall St. View

Price Prediction $126.58 +26.1% Our analysts’ 12-month view: target, optimistic case, and floor. Full prediction → Earnings Beat +18.9% EPS vs. the estimate, revenue, and how the market reacted. Total Earnings Coverage →

Fundamentals

Market Cap
$6.6B
P/E Ratio
24.0
Profit Margin
17.7%
Revenue (TTM)
$1.6B
EPS (TTM)
$4.19
52-Week Range
$50 – $112
Street Target
$107.74

About Lantheus

Lantheus Holdings Inc specializes in creating advanced diagnostic and therapeutic products that help doctors diagnose and treat diseases such as heart conditions, cancer, and more. Its portfolio includes DEFINITY for ultrasound exams, TechneLite for nuclear medicine, and innovative agents like PYLARIFY for prostate cancer imaging. Lantheus also explores cutting-edge technologies such as artificial intelligence to enhance disease detection and treatment. With collaborations across the healthcare industry, Lantheus is committed to improving patient outcomes through science. Founded in 1956, the company is headquartered in Bedford, Massachusetts.

LNTH Coverage